0001213900-19-021415.txt : 20191029
0001213900-19-021415.hdr.sgml : 20191029
20191029202654
ACCESSION NUMBER: 0001213900-19-021415
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191025
FILED AS OF DATE: 20191029
DATE AS OF CHANGE: 20191029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fletcher Aaron G.L.
CENTRAL INDEX KEY: 0001789490
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 191177113
MAIL ADDRESS:
STREET 1: 1751 RIVER RUN
STREET 2: SUITE 400
CITY: FT WORTH
STATE: TX
ZIP: 76107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2019-10-25
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001789490
Fletcher Aaron G.L.
2600 VIA FORTUNA, SUITE 360
AUSTIN
TX
78746
1
0
0
0
Common Stock
2019-10-25
4
P
0
2000
5.00
A
2000
D
Common Stock
2019-10-29
4
C
0
43919
A
45919
D
Warrants
5.00
2019-10-29
4
A
0
43794
0.00
A
2029-10-29
Common Stock
43794
179693
I
By: BP Directors, LP
Series A Preferred Stock
2019-10-29
4
C
0
43919
D
Common Stock
43919
135806
D
The shares of common stock purchased in the Issuer's initial public offering ("IPO").
The shares of Series A preferred stock automatically converted into the Issuer's common stock upon the completion of the Issuer's IPO at the conversion price of $2.50 per share.
25% of the warrants vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.
Not Applicable.
/s/ Aaron G.L. Fletcher, Ph.D., by Kirk Allen Coleman, as Attorney-in-Fact
2019-10-29